US-Singapore cooperation on tech and security: defense, cyber, and biotech
Shaun Kai Ern Ee

TL;DR
This paper analyzes the evolving US-Singapore partnership in defense, cyber, and biotech sectors, emphasizing collaborative opportunities amid geopolitical tensions and regional security challenges.
Contribution
It offers strategic recommendations for US-Singapore cooperation in defense, cybersecurity, and biosecurity to enhance regional security and resilience.
Findings
Singapore has transitioned from a defense technology purchaser to a collaborative partner.
Enhanced bilateral cooperation can address regional security threats more effectively.
Proposed joint initiatives include co-developing defense tech, improving cyber resilience, and strengthening bio-surveillance.
Abstract
The partnership between the United States and Singapore is founded in no small part on the shared recognition of the value that technology has for national security. Over the last 55 years, Singapore has become an established purchaser of U.S. defense technology, but the past 20 years have also seen the U.S.-Singapore relationship mature into an increasingly collaborative one, tackling newer fields like cybersecurity and biosecurity. However, current geopolitical tensions present a challenge for Singapore, which strives to retain its strategic autonomy by maintaining positive relations with all parties. Paradoxically, the rise of non-traditional security threats may pave the way for greater bilateral cooperation by allowing Singapore to position itself as a hub for cooperation on regional security issues in Southeast Asia at large. In such spirit, this paper recommends that the United…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBiotechnology and Related Fields · Law, AI, and Intellectual Property · Biomedical Ethics and Regulation
